Published in J Hyg (Lond) on April 01, 1978
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One (2010) 2.04
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65
Projection of seasonal influenza severity from sequence and serological data. PLoS Curr (2010) 1.03
Generation of cross-reactive cytotoxic T lymphocytes following immunization of mice with various bluetongue virus types. Immunology (1982) 0.98
Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol (2012) 0.89
Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning. Influenza Other Respir Viruses (2007) 0.87
High rate of A(H1N1)pdm09 infections among rural Thai villagers, 2009-2010. PLoS One (2014) 0.76
Relationship between surface antigens of two variants of influenza A (H3N2) virus, as revealed by hemagglutination inhibition, kinetic neutralization, and neuraminidase inhibition. Infect Immun (1980) 0.75
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) (1972) 7.42
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains. Virology (1974) 2.45
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28
Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet (1973) 1.77
[Selection of dominant mutants of the influenza A (Hong Kong) virus by immunological pressure]. C R Acad Sci Hebd Seances Acad Sci D (1973) 1.68
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Recombinant WRL 105 strain live attenuated influenza vaccine. Immunogenicity, reactivity, and transmissibility. Lancet (1975) 1.55
Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972. N Engl J Med (1973) 1.33
Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines. J Hyg (Lond) (1970) 1.08
[A new step in influenza vaccination. I. Prospective vaccine against influenza]. Nouv Presse Med (1973) 0.83
The British reference preparation for influenza virus haemagglutinin. J Hyg (Lond) (1971) 0.81
Isolation of anti-haemagglutinin antibodies with an influenza A virus immunoadsorbent. J Immunol Methods (1976) 0.81
Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet (1978) 11.99
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Determinants of immunity to influenza infection in man. Br Med Bull (1979) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Pseudomembranous colitis: Presence of clostridial toxin. Lancet (1978) 4.30
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
A quantitative, single-radial-diffusion test for immunological studies with influenza virus. J Gen Virol (1972) 3.69
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Work of a district ethical committee. Br Med J (1979) 3.64
Vaccination of rubella-susceptible women during oral contraceptive care in general practice. Br Med J (1977) 3.26
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Epidemiology of experimental enterocecitis due to Clostridium difficile. J Infect Dis (1980) 2.95
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol (1972) 2.78
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis (1982) 2.48
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand (1977) 2.46
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2.34
Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet (1979) 2.31
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Epidemiology of Clostridium difficile in infants. J Infect Dis (1982) 2.20
Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18
Evidence for a new type-specific structural antigen of the influenza virus particle. J Gen Virol (1972) 2.17
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Antibody against influenza A2 virus neuraminidase in human sera. J Hyg (Lond) (1969) 2.12
Coronaviridae: second report. Intervirology (1978) 2.05
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses. J Gen Virol (1969) 2.01
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
An antigenic variant of the Hong Kong-68 influenza A 2 virus. J Hyg (Lond) (1971) 1.95
Impairment of human polymorphonuclear leucocyte function by influenza virus. Lancet (1976) 1.93
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis (1971) 1.90
Antibiotic and pseudomembranous colitis. J Antimicrob Chemother (1981) 1.89
Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet (1984) 1.89
Serological epidemiological studies with influenza A viruses. J Hyg (Lond) (1965) 1.86
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Immunological relationships between the neuraminidases of human and animal influenza viruses. Bull World Health Organ (1969) 1.82
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3. Lancet (1982) 1.76
Simian virus 40-induced T and tumor antigens. J Virol (1969) 1.76
Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74
Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride. Br J Exp Pathol (1965) 1.73
Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol (1985) 1.72
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res (1984) 1.71
Immunity to influenza in ferrets. II. Influence of adjuvants on immunization. Br J Exp Pathol (1972) 1.70
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. J Hyg (Lond) (1975) 1.67
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Immunological and physicochemical studies of influenza matrix (M) polypeptides. Virology (1976) 1.66
The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. J Hyg (Lond) (1979) 1.65